186 related articles for article (PubMed ID: 33979978)
1. [Clinical features and treatment outcome of patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis].
Sun SR; Wu M; Wulipan F; Shen L; Ma JX; Chen PP; Hu YW; Zhang HD; Xie YH
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):324-331. PubMed ID: 33979978
[No Abstract] [Full Text] [Related]
2. Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
Tong H; Ren Y; Qian W; Xiao F; Mai W; Meng H; Jin J
Int J Hematol; 2009 Oct; 90(3):303-310. PubMed ID: 19728028
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
4. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
Song Y; Yin Q; Wang J; Wang Z
Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
[TBL] [Abstract][Full Text] [Related]
5. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis.
Huang DY; Hu YF; Wei N; Fu L; Wu L; Shen J; Wang JS; Wang Z
Chin Med J (Engl); 2019 Feb; 132(3):294-301. PubMed ID: 30681495
[TBL] [Abstract][Full Text] [Related]
6. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
7. [Clinical Analysis of B-Cell Non-Hodgkin Lymphoma Treated with Modified Conditioning Regimen].
Li YY; Chen ZH; Wang YF; Zhao ZG; Zhang YZ; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):469-473. PubMed ID: 33812417
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and prognosis of hyponatraemia in non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
Yin G; Man C; Cheng W; Gao X; Wang J; Tian T; Xu J; Duan L; Qiu H
Leuk Lymphoma; 2022 Feb; 63(2):362-369. PubMed ID: 34661498
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
10. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
[No Abstract] [Full Text] [Related]
13. Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
Cheng W; Duan L; Xu J; Shu Y; Qiu H; Yin G
Front Immunol; 2023; 14():1162320. PubMed ID: 37266439
[TBL] [Abstract][Full Text] [Related]
14. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Characteristics and Prognostic Factors of Children with Non-Hodgkin's Lymphoma of Different Pathological Subtypes].
Zheng YZ; Chen ZS; Hua XL; Zheng H; LE SH; Li J; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):500-506. PubMed ID: 32319386
[TBL] [Abstract][Full Text] [Related]
18. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
19. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome: a Retrospective Study.
Wu C; Liu H; Chen J
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]